FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics

cafead

Administrator
Staff member
  • cafead   May 16, 2023 at 12:22: PM
via News of the FTC’s pending challenge to the Amgen deal sunk Horizon’s stock during early morning trading Tuesday, with the company’s shares down more than 17%.

article source